Cerus (CERS) Other Non-Current Assets (2010 - 2026)
Cerus (CERS) reported Other Non-Current Assets of $11.2 million for Q1 2026, up 909.83% on a YoY basis from $1.1 million in Q1 2025, and up 1652.58% sequentially from $639000.0 in Q4 2025.
Cerus (CERS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Other Non-Current Assets data on file, last reported at $11.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 909.83% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (up 909.83% YoY), and the FY2025 full-year result was $639000.0, down 41.64% from the prior year.
- Other Non-Current Assets rose to $11.2 million in Q1 2026, from $639000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $20.9 million in Q1 2023 to a low of $639000.0 in Q4 2025.
- A 5-year average of $5.1 million and a median of $1.8 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 92.3% in 2025 and soared 909.83% in 2026, its largest moves.
- Tracing CERS's Other Non-Current Assets over 5 years: stood at $1.8 million in 2022, then retreated by 3.44% to $1.7 million in 2023, then sank by 36.04% to $1.1 million in 2024, then slumped by 41.64% to $639000.0 in 2025, then soared by 1652.58% to $11.2 million in 2026.
- Business Quant data shows CERS's Other Non-Current Assets at $11.2 million in Q1 2026, $639000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 285.90 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.25 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 164.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 828.89 Mn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 639,000.00 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 20.88 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 20.45 Mn |
| Dec 31, 2021 | 21.62 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Jun 30, 2021 | 8.77 Mn |